John Hoeven bought Celanese Corporation (NYSE: CE)
John Hoeven (R-ND), a U.S. Senator, has disclosed 1 trade in Celanese Corporation (CE) since 2019, a single purchase, worth an estimated $75K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: John Hoeven bought $50,001 - $100,000 of Celanese Corporation (NYSE: CE) on May 30, 2019. Since that trade, CE is down -49.54% against the S&P 500 up +190.21%, an outperformance of -239.75%.
Data updated
John Hoeven's CE trades vs the price
CE is down -49.54% since John Hoeven bought on May 30, 2019, versus +190.21% for the S&P 500.
Performance since this trade
All John Hoeven CE trades
John Hoeven & CE trading FAQ
Is it legal for John Hoeven to trade Celanese Corporation (CE) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Celanese Corporation (CE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John Hoeven buy CE?
John Hoeven disclosed a purchase of $50,001 - $100,000 of Celanese Corporation (CE) on May 30, 2019, according to public STOCK Act filings.
How has CE performed since John Hoeven's trade?
Since John Hoeven bought CE on May 30, 2019, the stock is down -49.54%, versus +190.21% for the S&P 500 over the same period, an outperformance of -239.75%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CE trades?
Quantellect tracks every disclosed congressional trade in Celanese Corporation (CE) on the Celanese Corporation congressional trading page, which aggregates filings across all members of Congress.
John Hoeven's CE tradesAll congressional filings for Celanese CorporationJohn Hoeven's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.